FYSIOMED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FYSIOMED
Largest movements
- Receivables within one year -€35,897
down €35,897 (-19.6%), from €183,134 to €147,237
of which Trade receivables: -€34,672
- Cash +€33,269
up €33,269 (+145%), from €22,968 to €56,237
mainly Trade debts (+€102,533) and Receivables within one year (+€35,897)
- Stocks and contracts -€14,111
down €14,111 (-5.5%), from €257,724 to €243,614
- Trade debts +€102,533
up €102,533 (+183%), from €56,042 to €158,575
- Profit (loss) carried forward -€88,370
down €88,370 (-33.7%), from -€261,965 to -€350,334
- Accrued charges and deferred income -€34,699
no longer reported in 2025 (was €34,699)
- Debts after one year -€9,953
down €9,953 (-12.1%), from €82,430 to €72,477
- Gross operating margin -€131,201
down €131,201 (-75.7%), from €173,327 to €42,127
- Staff costs -€23,907
down €23,907 (-22.5%), from €106,056 to €82,148
- Financial charges -€14,303
down €14,303 (-39.6%), from €36,118 to €21,816
- Financial income -€2,350
down €2,350 (-95.1%), from €2,472 to €122
- Depreciation +€1,919
up €1,919 (+11.2%), from €17,130 to €19,050
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €687,814 | €663,931 | -€23,883 | -3.5% |
| Fixed assets | 21/28 | €220,400 | €212,365 | -€8,035 | -3.6% |
| Tangible fixed assets | 22/27 | €209,006 | €205,361 | -€3,645 | -1.7% |
| Land and buildings | 22 | €200,092 | €184,808 | -€15,283 | -7.6% |
| Plant, machinery and equipment | 23 | €6,710 | €5,344 | -€1,366 | -20.4% |
| Furniture and vehicles | 24 | €2,204 | €15,208 | +€13,004 | +590% |
| Financial fixed assets | 28 | €11,394 | €7,004 | -€4,390 | -38.5% |
| Current assets | 29/58 | €467,414 | €451,566 | -€15,848 | -3.4% |
| Stocks and contracts in progress | 3 | €257,724 | €243,614 | -€14,111 | -5.5% |
| Stocks | 30/36 | €257,724 | €243,614 | -€14,111 | -5.5% |
| Amounts receivable within one year | 40/41 | €183,134 | €147,237 | -€35,897 | -19.6% |
| Trade receivables | 40 | €178,845 | €144,173 | -€34,672 | -19.4% |
| Other amounts receivable | 41 | €4,288 | €3,063 | -€1,225 | -28.6% |
| Cash at bank and in hand | 54/58 | €22,968 | €56,237 | +€33,269 | +145% |
| Deferred charges and accrued income | 490/1 | €3,587 | €4,479 | +€891 | +24.8% |
| Total equity and liabilities | 10/49 | €687,814 | €663,931 | -€23,883 | -3.5% |
| Equity | 10/15 | €206,971 | €118,601 | -€88,370 | -42.7% |
| Contributions | 10/11 | €285,000 | €285,000 | = | 0.0% |
| Capital | 10 | €285,000 | €285,000 | = | 0.0% |
| Issued capital | 100 | €285,000 | €285,000 | = | 0.0% |
| Reserves | 13 | €183,936 | €183,936 | = | 0.0% |
| Non-distributable reserves | 130/1 | €15,000 | €15,000 | = | 0.0% |
| Legal reserve | 130 | €15,000 | €15,000 | = | 0.0% |
| Tax-exempt reserves | 132 | €19,335 | €19,335 | = | 0.0% |
| Distributable reserves | 133 | €149,600 | €149,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€261,965 | -€350,334 | -€88,370 | -33.7% |
| Amounts payable | 17/49 | €480,843 | €545,330 | +€64,486 | +13.4% |
| Amounts payable after more than one year | 17 | €82,430 | €72,477 | -€9,953 | -12.1% |
| Financial debts | 170/4 | €82,430 | €72,477 | -€9,953 | -12.1% |
| Amounts payable within one year | 42/48 | €363,714 | €472,852 | +€109,138 | +30.0% |
| Current portion of amounts payable after more than one year | 42 | €17,001 | €20,998 | +€3,997 | +23.5% |
| Financial debts | 43 | €275,000 | €275,000 | = | 0.0% |
| Credit institutions | 430/8 | €275,000 | €275,000 | = | 0.0% |
| Trade debts | 44 | €56,042 | €158,575 | +€102,533 | +183% |
| Suppliers | 440/4 | €56,042 | €158,575 | +€102,533 | +183% |
| Taxes, remuneration and social security | 45 | €15,624 | €12,233 | -€3,391 | -21.7% |
| Taxes | 450/3 | €4,592 | €3,136 | -€1,456 | -31.7% |
| Remuneration and social security | 454/9 | €11,032 | €9,097 | -€1,935 | -17.5% |
| Other amounts payable | 47/48 | €47 | €6,046 | +€5,999 | +12,724% |
| Accrued charges and deferred income | 492/3 | €34,699 | - | -€34,699 | |
| Non-recurring operating income | 76A | €826 | - | -€826 | |
| Remuneration, social security and pensions | 62 | €106,056 | €82,148 | -€23,907 | -22.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €17,130 | €19,050 | +€1,919 | +11.2% |
| Other operating charges | 640/8 | €8,214 | €6,903 | -€1,310 | -16.0% |
| Gross operating margin | 9900 | €173,327 | €42,127 | -€131,201 | -75.7% |
| Operating profit (loss) | 9901 | €41,928 | -€65,974 | -€107,903 | |
| Financial income | 75/76B | €2,472 | €122 | -€2,350 | -95.1% |
| Recurring financial income | 75 | €2,472 | €122 | -€2,350 | -95.1% |
| Financial charges | 65/66B | €36,118 | €21,816 | -€14,303 | -39.6% |
| Recurring financial charges | 65 | €36,118 | €21,816 | -€14,303 | -39.6% |
| Profit (loss) for the period before taxes | 9903 | €8,281 | -€87,668 | -€95,950 | |
| Income taxes | 67/77 | €732 | €701 | -€31 | -4.3% |
| Profit (loss) for the period | 9904 | €7,549 | -€88,370 | -€95,918 | |
| Profit (loss) for the period to be appropriated | 9905 | €7,549 | -€88,370 | -€95,918 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.